Smith M - Search Results

1

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.

Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS, Oh W, Demetri G, Figg WD, Zhou XP, Eng C, Spiegelman BM, Kantoff PW. Mueller E, et al. Among authors: smith m. Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10990-5. doi: 10.1073/pnas.180329197. Proc Natl Acad Sci U S A. 2000. PMID: 10984506 Free PMC article. Clinical Trial.

2

Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.

Smith MR, Kantoff PW. Smith MR, et al. Semin Oncol. 1995 Dec;22(6):625-32. Semin Oncol. 1995. PMID: 8539637 Review.

3

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G, et al. Bubley GJ, et al. Among authors: smith mr. J Clin Oncol. 1999 Nov;17(11):3461-7. doi: 10.1200/JCO.1999.17.11.3461. J Clin Oncol. 1999. PMID: 10550143

4

Genitourinary malignancies.

Smith MR, Kantoff P. Smith MR, et al. Cancer Chemother Biol Response Modif. 1999;18:394-417. Cancer Chemother Biol Response Modif. 1999. PMID: 10800495 Review. No abstract available.

5

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II study.

Smith MR, Kaufman D, Oh W, Guerin K, Seiden M, Makatsoris T, Manola J, Kantoff PW. Smith MR, et al. Cancer. 2000 Oct 15;89(8):1824-8. doi: 10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r. Cancer. 2000. PMID: 11042579 Clinical Trial.

6

Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer.

Kelly WK, Curley T, Slovin S, Heller G, McCaffrey J, Bajorin D, Ciolino A, Regan K, Schwartz M, Kantoff P, George D, Oh W, Smith M, Kaufman D, Small EJ, Schwartz L, Larson S, Tong W, Scher H. Kelly WK, et al. Among authors: smith m. J Clin Oncol. 2001 Jan 1;19(1):44-53. doi: 10.1200/JCO.2001.19.1.44. J Clin Oncol. 2001. PMID: 11134194 Clinical Trial.

7

Low bone mineral density in hormone-naïve men with prostate carcinoma.

Smith MR, McGovern FJ, Fallon MA, Schoenfeld D, Kantoff PW, Finkelstein JS. Smith MR, et al. Cancer. 2001 Jun 15;91(12):2238-45. Cancer. 2001. PMID: 11413511

8

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

Smith MR, McGovern FJ, Zietman AL, Fallon MA, Hayden DL, Schoenfeld DA, Kantoff PW, Finkelstein JS. Smith MR, et al. N Engl J Med. 2001 Sep 27;345(13):948-55. doi: 10.1056/NEJMoa010845. N Engl J Med. 2001. PMID: 11575286 Free article. Clinical Trial.

9

[Metastatic prostate carcinoma].

Smith MR, Kantoff P, Talcott J. Smith MR, et al. Praxis (Bern 1994). 2001 Sep 20;90(38):1653-8. Praxis (Bern 1994). 2001. PMID: 11675919 German. No abstract available.

10

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report.

Oh WK, George DJ, Kaufman DS, Moss K, Smith MR, Richie JP, Kantoff PW. Oh WK, et al. Among authors: smith mr. Semin Oncol. 2001 Aug;28(4 Suppl 15):40-4. doi: 10.1016/s0093-7754(01)90153-8. Semin Oncol. 2001. PMID: 11685727 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,667 results

Search Page

Filters